These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 8733774)

  • 1. DNA image analysis of urinary cytology: prediction of recurrent transitional cell carcinoma.
    de la Roza GL; Hopkovitz A; Caraway NP; Kidd L; Dinney CP; Johnston D; Katz RL
    Mod Pathol; 1996 May; 9(5):571-8. PubMed ID: 8733774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination of cytologic evaluation and quantitative digital cytometry is reliable in detecting recurrent disease in patients with urinary diversions.
    Caraway NP; Khanna A; Payne L; Kamat AM; Katz RL
    Cancer; 2007 Oct; 111(5):323-9. PubMed ID: 17721991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluorescence in situ hybridization performed on exfoliated urothelial cells in patients with transitional cell carcinoma of the bladder.
    Degtyar P; Neulander E; Zirkin H; Yusim I; Douvdevani A; Mermershtain W; Kaneti J; Manor E
    Urology; 2004 Feb; 63(2):398-401. PubMed ID: 14972510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening for urothelial malignancies by cytologic analysis and flow cytometry in a community urologic practice: a prospective study.
    Gourlay W; Chan V; Gilks CB
    Mod Pathol; 1995 May; 8(4):394-7. PubMed ID: 7567937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of static cytometry in transitional cell carcinoma of the bladder: recurrence rate and survival in a group of patients at 10 years follow-up.
    Cai T; Margallo E; Nesi G; Giubilei G; Rizzo M; Bartoletti R
    Oncol Rep; 2006 Jan; 15(1):213-9. PubMed ID: 16328058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluorescence in situ hybridization for detecting upper urinary tract tumors--a preliminary report.
    Akkad T; Brunner A; Pallwein L; Gozzi C; Bartsch G; Mikuz G; Steiner H; Verdorfer I
    Urology; 2007 Oct; 70(4):753-7. PubMed ID: 17991550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Urinary BTA-TRAK in the follow-up of superficial transitional-cell bladder carcinoma].
    Fernández Gómez JM; García Rodríguez J; Escaf Barmadah S; Raigoso P; Rodríguez Martínez JJ; Allende MT; Casasola Chamorro J; Rodríguez Faba O; Martín Benito JL; Regadera Sejas FJ
    Arch Esp Urol; 2002; 55(1):41-9. PubMed ID: 11957750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA image cytometry and fluorescence in situ hybridization for noninvasive detection of urothelial tumors in voided urine.
    Dalquen P; Kleiber B; Grilli B; Herzog M; Bubendorf L; Oberholzer M
    Cancer; 2002 Dec; 96(6):374-9. PubMed ID: 12478686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic value of cytology of voided urine.
    Koss LG; Deitch D; Ramanathan R; Sherman AB
    Acta Cytol; 1985; 29(5):810-6. PubMed ID: 3863429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative diagnostic value of urine cytology, UBC-ELISA, and fluorescence in situ hybridization for detection of transitional cell carcinoma of urinary bladder in routine clinical practice.
    May M; Hakenberg OW; Gunia S; Pohling P; Helke C; Lübbe L; Nowack R; Siegsmund M; Hoschke B
    Urology; 2007 Sep; 70(3):449-53. PubMed ID: 17688921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prognostic significance of DNA content in transitional cell carcinoma of the urinary bladder].
    Sun X
    Zhonghua Zhong Liu Za Zhi; 1992 Jan; 14(1):24-6. PubMed ID: 1396041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Near tetraploid prostate carcinoma. Methodologic and prognostic aspects.
    Forsslund G; Nilsson B; Zetterberg A
    Cancer; 1996 Oct; 78(8):1748-55. PubMed ID: 8859188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Results of Bard BTA test in monitoring patients with a history of transitional cell cancer of the bladder.
    Ianari A; Sternberg CN; Rossetti A; Van Rijn A; Deidda A; Giannarelli D; Pansadoro V
    Urology; 1997 May; 49(5):786-9. PubMed ID: 9145993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of flow and image DNA cytometry in prediction of patient prognosis in surgically resected small cell lung cancer.
    Carey FA; Gray E; O'Mahony M; Craig SR; Salto-Tellez M; Lamb D
    Anal Cell Pathol; 1996 Dec; 12(3):137-43. PubMed ID: 9025990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accuracy of urinary cytology in the diagnosis of primary and recurrent bladder cancer.
    Wiener HG; Vooijs GP; van't Hof-Grootenboer B
    Acta Cytol; 1993; 37(2):163-9. PubMed ID: 8465635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative assessment of bladder cancer by nuclear texture analysis using automated high resolution image cytometry.
    Gschwendtner A; Hoffmann-Weltin Y; Mikuz G; Mairinger T
    Mod Pathol; 1999 Aug; 12(8):806-13. PubMed ID: 10463483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Benign squamous cells with pleomorphic microvilli in urine or bladder washings.
    Suzuki T; St John M; Cohen SM; Friedell GH
    Acta Cytol; 1983; 27(5):497-9. PubMed ID: 6578647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of NMP22 BladderChek test and urine cytology for the detection of recurrent bladder cancer.
    Kumar A; Kumar R; Gupta NP
    Jpn J Clin Oncol; 2006 Mar; 36(3):172-5. PubMed ID: 16520358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of cytology, nuclear matrix protein 22 (NMP22) test, and urinary bladder cancer II (UBC II) test in early recurrent transitional cell carcinoma of the bladder.
    Kibar Y; Goktas S; Kilic S; Yaman H; Onguru O; Peker AF
    Ann Clin Lab Sci; 2006; 36(1):31-8. PubMed ID: 16501234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the telomeric repeat amplification protocol (TRAP) assay for telomerase as a diagnostic modality in recurrent bladder cancer.
    Dalbagni G; Han W; Zhang ZF; Cordon-Cardo C; Saigo P; Fair WR; Herr H; Kim N; Moore MA
    Clin Cancer Res; 1997 Sep; 3(9):1593-8. PubMed ID: 9815848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.